SCHEMBL845189

SCHEMBL845189

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3)cc2)cc1)c1ccccc1NCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
ITGB1 P05556 8/20 0.46
ITGA4 P13612 8/20 0.46
HSD17B10 Q99714 1/20 0.45
HCRTR1 O43613 2/20 0.45
HCRTR2 O43614 2/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
USP2 O75604 1/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845682 0.87 ALDH1A1 (0.54) ALDH1A1HSD17B10MEN1KMT2AUSP2
SCHEMBL1030175 0.87 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HSD17B10HCRTR1
SCHEMBL13272444 0.87 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HSD17B10HCRTR1
SCHEMBL845205 0.87 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HSD17B10HCRTR1
SCHEMBL845111 0.87 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HSD17B10HCRTR1
SCHEMBL15116912 0.87 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HSD17B10HCRTR1
SCHEMBL845226 0.87 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HSD17B10HCRTR1
SCHEMBL845484 0.86 ALDH1A1 (0.48) ALDH1A1ITGB1ITGA4HSD17B10HCRTR1
SCHEMBL845376 0.86 ALDH1A1 (0.44) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL845415 0.85 ALDH1A1 (0.51) ALDH1A1ITGB1ITGA4HSD17B10HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed